Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma

This study is ongoing, but not recruiting participants.

Study NCT00002882 Information provided by National Cancer Institute (NCI)

First Received: November 1, 1999 Last Updated: October 29, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Melanoma (Skin)

Additional conditions recognized in this trial

Melanoma

More general conditions related to this trial

Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas

Interventions listed in this trial

aldesleukin
recombinant interferon alfa
cisplatin
dacarbazine
vinblastine
adjuvant therapy

Additional drug interventions recognized in this trial

Adjuvants, Immunologic
Interferon Alfa-2a
Interferon Type I, Recombinant
Interferon-alpha
Interferons

Sponsors listed in this trial

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Back to top of Main Content